Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21972208 | 0.83 | GPR3 (0.43) | BRDTGPR3KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL19001870 | 0.77 | GPR3 (0.46) | BRDTSLC9A1GPR3KDM4EMAPT | |
| SCHEMBL21971993 | 0.77 | F9 (0.38) | BRDTSLC9A1GPR3MAPT | |
| SCHEMBL25470273 | 0.76 | ENPP1 (0.36) | BRDTGPR3KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL21742520 | 0.76 | GPR3 (0.45) | BRDTSLC9A1GPR3KDM4EMAPT | |
| SCHEMBL25456509 | 0.76 | MAP3K9 (0.39) | BRDTGPR3MAPT | |
| SCHEMBL21971533 | 0.75 | GPR3 (0.42) | BRDTGPR3MAPTSMN1; SMN2 | |
| SCHEMBL25700671 | 0.75 | GPR3 (0.35) | BRDTSLC9A1GPR3KDM4EMAPT | |
| SCHEMBL25456508 | 0.74 | SLC9A1 (0.40) | BRDTSLC9A1GPR3MAPTSMN1; SMN2 | |
| SCHEMBL21971534 | 0.74 | BRDT (0.38) | BRDTGPR3KDM4EMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230041530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, CHRM1 | BRDT 586/4885SLC9A1 1206/4885GPR3 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.